http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106645752-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-46 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106645752-B |
| titleOfInvention | Galectin 10 and its specific antibody are preparing the application in detecting nasopharyngeal carcinoma kit |
| abstract | The present invention relates to diagnosis marker, specifically disclose a kind of nasopharyngeal carcinoma Research of predicting markers Galectin 10 (genebank accession number ID1178), and provide the mark and its specific antibody and preparing the application in detecting nasopharyngeal carcinoma kit, the kit can be immunohistochemical kit or enzyme-linked immunologic detecting kit.Early discovery and the early treatment of nasopharyngeal carcinoma can be achieved effectively to judge that people's naso-pharynageal disease process provides new scientific basis in the present invention. |
| priorityDate | 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.